Metraipolis › archive › dc_9fa080798dc7

Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life — Europe PMC PMID:40830718

Source: Europe PMC (en)
Original: https://europepmc.org/article/MED/40830718
DOI: 10.1007/s11102-[numero omesso]-7
License (as archived): solo-consultazione
Archived: 2026-11-10T12:56:59.569Z
SHA-256 of the archived text: 098f1c4f779da183ea46f155213d80efa4f2100b53e102f20ad8c0988d9076f6
Stable URL of this page: https://metraipolis.com/documento/dc_9fa080798dc7

How to cite

Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life — Europe PMC PMID:40830718 — Europe PMC (en), https://europepmc.org/article/MED/40830718 (solo-consultazione); archived copy: https://metraipolis.com/documento/dc_9fa080798dc7 (Metraipolis archive dc_9fa080798dc7, sha256 098f1c4f779da183ea46f155213d80efa4f2100b53e102f20ad8c0988d9076f6)

BibTeX

@misc{dc9fa080798dc7,
  title = {Semaglutide treatment in hypothalamic obesity: Two-Year outcomes on body composition, appetite, and quality of life — Europe PMC PMID:40830718},
  howpublished = {Europe PMC (en)},
  url = {https://europepmc.org/article/MED/40830718},
  note = {License solo-consultazione; archived copy https://metraipolis.com/documento/dc_9fa080798dc7; sha256 098f1c4f779da183ea46f155213d80efa4f2100b53e102f20ad8c0988d9076f6},
  year = {2026}
}

Archived text

The text is not reproduced here: the archive holds it as solo-consultazione (consultation only, no republication). Read it at the original source: https://europepmc.org/article/MED/40830718. Agents can read the archived copy with the MCP tool read_document.